Results 1 to 10 of about 67,362 (119)

Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib

open access: yesFrontiers in Oncology, 2021
Tyrosine kinase inhibitors (TKIs) have radically changed the outcome of chronic myeloid leukemia (CML) patients in the last 20 years. Moreover, the advent of second generation TKIs, namely nilotinib and dasatinib, have largely increased the number of CML
Federica Loscocco   +14 more
doaj   +1 more source

Influence of gut microbiome on multiple myeloma: friend or foe?

open access: yesJournal for ImmunoTherapy of Cancer, 2020
Multiple myeloma (MM) is a malignancy of terminally differentiated plasma cells, which typically evolves over time from its precursor, monoclonal gammopathy of undetermined significance.
Marcos de Lima   +4 more
doaj   +1 more source

Successful treatment of pulmonary hypertension following hematopoietic stem cell transplant with a single oral tadalafil: a case report

open access: yesPulmonary Circulation, 2021
A 46‐year‐old man who had undergone hematopoietic stem cell transplant twice because of acute lymphoblastic leukemia with recurrence presented with dyspnea, leading to a diagnosis of pulmonary arterial hypertension which was quickly and effectively ...
Toshikazu D. Tanaka   +4 more
doaj   +1 more source

Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: Adults

open access: yesEinstein (São Paulo), 2020
The nutritional status of patients submitted to hematopoietic stem cell transplant is considered an independent risk factor, which may influence on quality of life and tolerance to the proposed treatment.
Juliana Bernardo Barban   +31 more
doaj   +2 more sources

Intramuscular Injection of Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis Patients: A Randomized Clinical Trial

open access: yesFrontiers in Neuroscience, 2020
BackgroundPreclinical studies suggest that stem cells may be a valuable therapeutic tool in amyotrophic lateral sclerosis (ALS). As it has been demonstrated that there are molecular changes at the end-plate during the early stages of motorneuron ...
Emilio Geijo-Barrientos   +18 more
doaj   +1 more source

Fungal infections in hematopoietic stem-cell transplant patients: a review of epidemiology, diagnosis, and management

open access: yesTherapeutic Advances in Infectious Disease, 2021
The advent of bone marrow transplant has opened doors to a different approach and offered a new treatment modality for various hematopoietic stem-cell-related disorders.
Mandeep Singh Rahi   +7 more
doaj   +1 more source

Caring for AML Patients During the COVID-19 Crisis: An American and Italian Experience

open access: yesFrontiers in Oncology, 2020
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the subsequent pandemic have impacted every aspect of oncology care worldwide.
Lindsay Wilde   +4 more
doaj   +1 more source

Adding hydroxyurea in combination with ruxolitinib improves clinical responses in hyperproliferative forms of myelofibrosis

open access: yesCancer Medicine, 2019
Ruxolitinib, an orally bioavailable and selective inhibitor of Janus kinase 1 (JAK1) and JAK2, significantly reduces splenomegaly and disease‐related symptoms in patients with myelofibrosis (MF).
Novella Pugliese   +14 more
doaj   +1 more source

Methotrexate-Induced Acute Leukemia: Report of Three Cases and Review of the Literature

open access: yesClinical Medicine Insights: Case Reports, 2009
For many years, methotrexate has been used in the treatment of certain chronic medical disorders e.g. rheumatoid arthritis and psoriasis as well as a number of malignant disorders e.g.
Khalid A. Al-Anazi   +3 more
doaj   +1 more source

Endocrinopathies after Allogeneic and Autologous Transplantation of Hematopoietic Stem Cells

open access: yesThe Scientific World Journal, 2014
Early and late endocrine disorders are among the most common complications in survivors after hematopoietic allogeneic- (allo-) and autologous- (auto-) stem cell transplant (HSCT).
Francesco Orio   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy